Uddrag fra opgaven
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 14 December 2000 CPMP/EWP/QWP/1401/98 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON THE INVESTIGATION OF BIOAVAILABILITY AND BIOEQUIVALENCE DISCUSSION IN THE JOINT EFFICACY AND QUALITY WORKING GROUP December 1997October 1998 TRANSMISSION TO THE CPMP July 1998 RELEASE FOR CONSULTATION December 1998 DEADLINE FOR COMMENTS June 1999 DISCUSSION IN THE DRAFTING GROUP February – May 2000 TRANSMISSION TO THE CPMP July - December 2000 RELEASE FOR CONSULTATION December 2000 DEADLINE FOR COMMENTS March 2001 Note: This revised Note for Guidance will replace the
Få fri adgang for at læse hele teksten og downloade ubegrænset.
Få fri adgang